Investor AB Investor Day Presentation Deck

● STRONG FINANCIAL DEVELOPMENT ● 123 $M Revenue 2019 PF Pro forma for Clinical Innovations acquisition = 2016 275 70 205 Laborie Clinical Innovations 2019PF = % Adj EBITA Margin 2019 PF Pro forma for Clinical Innovations acquisition YTD 2020 Commentary 25% 2016 Copyright Laborie Medical Technologies 2020 29% 2019PF Organic growth and operating margin sharply lower in Legacy Laborie business due to significant drop in elective procedures Slight growth and improved operating margin in maternal and child care business due more limited impact from decline in non-elective procedures LABORIE 118

View entire presentation